Juice_TBH659
Active member
The main risk might be drawing scrutiny from regulators who must justify their existence by identifying an infraction.
I hope this doesn't affect too many options.Juice_TBH659 said:The FDA’s recent regulatory crackdown on tirzepatide compounding has far-reaching implications for both pharmacies and patients. Strict deadlines have been set for compounding pharmacies to stop producing tirzepatide, leaving many individuals concerned about affordable access and treatment continuity.
SparkleStacy_RX said:I'd Like to use them but price is an obstacle, to Add them to my TRT regimen, .....
Well, Ramen noodles are cheap.....
We use cookies to provide forum features. Optional analytics cookies are only used with your consent. Cookie Policy